UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma
- 15 January 2000
- Vol. 88 (2) , 318-323
- https://doi.org/10.1002/(sici)1097-0142(20000115)88:2<318::aid-cncr11>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Experience With New Chemotherapeutic Agents in Non-small Cell Lung CancerChest, 1998
- Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II studyEuropean Journal Of Cancer, 1995
- A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancerCancer, 1995
- Pharmacokinetics of Leucovorin Metabolites in Human Plasma as a Function of Dose Administrated Orally and IntravenouslyJNCI Journal of the National Cancer Institute, 1991
- A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.Journal of Clinical Oncology, 1990
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1990
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- Adjuvant chemotherapy with Cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neckCancer, 1983